ArticleJournal of Cancer2023

The prognostic value of including S-1 regimens in stage II and III gastric cancer patients: A propensity score matching and subgroup analyses.

Yifan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.